Arcus Biosciences' estimated fair value is US$41.75 based on 2 Stage Free Cash Flow to Equity Arcus Biosciences is estimated to be 39% undervalued based on current share price of US$25.56 The US$32.22 ...
The projected fair value for Algoma Central is CA$17.81 based on Dividend Discount Model Current share price of CA$18.47 suggests Algoma Central is potentially trading close to its fair value Industry ...
Accenture's estimated fair value is US$276 based on 2 Stage Free Cash Flow to Equity. With US$245 share price, Accenture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback